New Non-Hormonal Treatment by Radiofrequency for Vulvo-Vaginal Atrophy (ViViA)
Thermal Treatment of Vulvo-vaginal Atrophy (VVA) Using Novel Low-energy Dynamic Quadripolar Radio-Frequency (DQRF)
Sponsor: Centre Hospitalier Universitaire Brugmann
Terminated
The study was delayed due to the Covid 19 pandemic. The study was stopped prematurely due to a lack of efficiency (reported by the patients)
Other Genitourinary Syndrome of Menopause trials with similar outcome
A NA clinical study on Genitourinary Syndrome of Menopause and Vulvo-vaginal Atrophy, this trial is terminated or withdrawn. The trial is conducted by Centre Hospitalier Universitaire Brugmann and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2022 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — Apr 2022 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
May 2019 — Aug 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2019 — May 2019 [monthly]
Not Yet Recruiting NA
-
Mar 2019 — Apr 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire Brugmann
- Erasme University Hospital
- Hôpitaux IRIS Sud
- Jules Bordet Institute
- NOVAVISION GROUP S.P.A
- Serge Rozenberg
For direct contact, visit the study record on ClinicalTrials.gov .